News & Updates

Treatment with rosuvastatin appears to significantly reduce the progression of carotid intima-media thickness (CIMT) over 2 years in Asian patients with subclinical atherosclerosis, a study has shown.

Mums’ use of corticosteroids during pregnancy may put children at risk of developing psychological developmental and neurosensory disorders over the long term, as shown in a large cohort study.

New drug applications approved by US FDA as of 16 - 31 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A 10-day course of probiotics containing two strains of lactobacilli does not appear to improve vaginal microbiome quality in women planning to undergo in vitro fertilization (IVF), according to results of a recent study presented at ESHRE 2022.

The use of estrogen replacement therapy appears to yield a risk-lowering effect on gastric and colorectal cancers, as reported in a retrospective study.

Several adult patients with eosinophilic esophagitis (EoE) poorly adhere to their maintenance treatment, a recent study has found.

In many patients receiving long-term hydroxychloroquine therapy, retinal thickness remains stable for years but may start to thin quickly after a critical point, according to a recent study.